Events2Join

Can a Genomic Test Better Detect Aggressive Prostate Cancer?


Where to access genetic testing for prostate cancer risk

If you would like to learn more ask your GP to refer you to the local NHS genetics clinic. You will usually be sent a family history questionnaire for ...

Genetic testing for prostate cancer: Role, tests, and more

Genetic testing can identify specific genetic changes that raise the risk of prostate cancer. Some people with a family history of cancer may benefit from ...

Genetic testing for hereditary prostate cancer risk - Invitae

Prostate cancer genetic testing can reveal a patient's potential risk of more aggressive disease to help inform next steps.

Gene Expression Profiling and Protein Biomarkers for Prostate Cancer

The FDA has approved two tests for evaluation of gene expression profiles of prostate cancer as of April 2, 2019.

Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)

Clinicians may begin prostate cancer screening and offer a baseline PSA test to people between ages 45 to 50 years. (Conditional Recommendation; Evidence Level: ...

Hereditary Prostate Cancer - Memorial Sloan Kettering Cancer Center

Most prostate cancers are not associated with a hereditary predisposition, but prostate cancers that have spread or are more aggressive are more likely to be ...

Genetic risk factors for prostate cancer - UpToDate

Males with germline mutations in BRCA2, in particular, are at increased risk of prostate cancer and have more aggressive disease features.

At-home saliva test could help diagnose prostate cancer sooner

A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial.

Prostate Cancer: Advancements in Screenings

More accurate: This test is better at detecting prostate cancer. It can also detect whether you have a more aggressive type of cancer. This information can ...

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test ...

The data support the clinical performance of the Galleri test to preferentially screen for aggressive, clinically significant prostate cancer.

New urine-based test detects high grade prostate cancer, helping ...

To make MyProstateScore even stronger at identifying high grade cancers, researchers used RNA sequencing of more than 58,000 genes and narrowed ...

Study finds marker of aggressive prostate cancer – WashU Medicine

With improving diagnosis and treatment in mind, Maher said the development of a noninvasive test to measure levels of PCAT-14 could reduce the need for biopsy ...

Veracyte's Genetic Test Predicts Black Men's Aggressive Prostate ...

Clinical data shows the AI-based transcriptome biomarker, developed using primarily White men, also accurately predicts prostate cancer in ...

Prostate Cancer Diagnosis and Staging - Medscape Reference

In prospective multicenter studies, the PHI test outperformed free and total PSA for detection of prostate cancer and improved prediction of ...

Ushering in a New Era of Personalized Treatment for Advanced ...

With high-quality biomarker testing and more genomic data available, we're also able to identify new biomarkers in prostate cancer that can help ...

Genetic Testing For Prostate Cancer | BRCA - YouTube

... prostate cancer patients? 10:14 What are the usual next steps after a patient gets their genetic test results? 10:45 How can patients best ...

Men with a susceptibility to prostate cancer and the role of genetic ...

Genomic tests, utilising somatic (prostate biopsy) tissue can also predict the risk of unfavourable pathology, biochemical recurrence and the likelihood of ...

Personalized PSA levels could improve prostate cancer screening

... prostate cancer could lie in every man's genome. Stanford Medicine ... more accurately determine when a PSA test indicates prostate cancer.

Diagnosis of Prostate Cancer - UCLA Health

MRI is the best test to non-invasively identify suspicious lesions within the prostate which can help guide the location of a biopsy.

Overview of the Decipher® Genomic Classifier - UroToday

Performed on a specimen from a prostate biopsy or surgery, the test provides a score that represents the aggressiveness of the cancer. The score helps in ...